Drug Trial Radar · NCT04476030
A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Dec 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
440
Actual
Start
Nov 9, 2020
Primary completion
Oct 25, 2021
Study completion Dec 22, 2021
Sponsor
- Lead sponsor
- BiogenBiogen (BIIB)
- Sponsor type
- Industry
- First posted
- Jul 17, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate the efficacy of SAGE-217 plus an ADT in the treatment of major depressive disorder (MDD) compared to placebo plus an ADT.
Conditions
- Depressive Disorder, Major
Interventions
SAGE-217Drug
Oral capsules
Matching PlaceboDrug
Oral capsules
SertralineDrug
Oral tablets
EscitalopramDrug
Oral tablets
CitalopramDrug
Oral tablets
DuloxetineDrug
Oral capsules
DesvenlafaxineDrug
Oral tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the HAMD-17 Total Score at Day 3Time frame: Baseline, Day 3
Locations
51 sites in 1 country. Site status is shown where the registry gives one.
Sage Investigational Site
Dothan, Alabama
Sage Investigational Site
Phoenix, Arizona
Sage Investigational Site
Anaheim, California
Sage Investigational Site
Costa Mesa, California
Sage Investigational Site
Glendale, California
Sage Investigational Site
Irvine, California
Sage Investigational Site
Los Alamitos, California
Sage Investigational Site
Oceanside, California
Sage Investigational Site
Orange, California
Sage Investigational Site
Riverside, California
Sage Investigational Site
San Diego, California
Sage Investigational Site
Temecula, California
Sage Investigational Site
Colorado Springs, Colorado
Sage Investigational Site
Cromwell, Connecticut
Sage Investigational Site
Norwich, Connecticut
Sage Investigational Site
Coral Springs, Florida
Sage Investigational Site
Jacksonville, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Orlando, Florida
Sage Investigational Site
Pensacola, Florida
Sage Investigational Site
Alpharetta, Georgia
Sage Investigational Site
Atlanta, Georgia
Sage Investigational Site
Marietta, Georgia
Sage Investigational Site
Savannah, Georgia
Sage Investigational Site
Chicago, Illinois
Sage Investigational Site
Chicago, Illinois
Sage Investigational Site
Towson, Maryland
Sage Investigational Site
Watertown, Massachusetts
Sage Investigational Site
Ann Arbor, Michigan
Sage Investigational Site
Saint Charles, Missouri
Sage Investigational Site
Lincoln, Nebraska
Sage Investigational Site
Cherry Hill, New Jersey
Sage Investigational Site
Marlton, New Jersey
Sage Investigational Site
Princeton, New Jersey
Sage Investigational Site
Albuquerque, New Mexico
Sage Investigational Site
Brooklyn, New York
Sage Investigational Site
Brooklyn, New York
Sage Investigational Site
Mount Kisco, New York
Sage Investigational Site
Beachwood, Ohio
Sage Investigational Site
Cincinnati, Ohio
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.